Survival analysis of adult visceral leishmaniasis patients admitted to Metema Hospital, Metema, Ethiopia: a hospital-based cross-sectional study
Authors:
- 6 June 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 118 (11) , 736-743
Abstract
Background: Visceral leishmaniasis (VL) is a neglected tropical disease that mostly affects the working class and impoverished segments of society, having a significant negative effect on the economic development of the affected nation. While anti-leishmanial medications lower mortality among VL patients, patients may still die or require more time to recover while receiving treatment. In this regard, there are limited studies in Ethiopia. This study aims to determine the time to recovery and its associated predictors among adult VL patients at Metema Hospital, Metema, Ethiopia. Methods: A hospital-based cross-sectional study was employed and the data were collected from patient's charts from September 2017 to September 2021. Data were entered and analysed using EpiData version 3.1, Stata version 14.2 and R version 3.4.0 statistical software. Kaplan–Meier survival curves and logrank tests were used to compare the survival time. The Cox proportional hazards model assumption and model fitness were checked and used to identify statistical association predictors in VL patients. Results: The Cox proportional hazards model was fitted. The overall medium recovery time was 7 d (minimum 4, maximum 14). The variables of nasal bleeding (adjusted hazard ratio [aHR] 0.44 [95% confidence interval {CI} 0.19 to 0.89]), no comorbidity (aHR 2.29 [95% CI 1.27 to 4.11]), relapse of VL (aHR 0.33 [95% CI 0.15 to 0.75]), low parasite load (aHR 2.58 [95% CI 1.48 to 4.51]) and ambulatory (aHR 3.26 [95% CI 2.45 to 6.53]) were significantly associated with time to recovery in VL patients. Conclusions: Patients with comorbidities, nasal bleeding, relapse of VL, bedridden and high parasite load should be treated and monitored carefully to recover quickly from their illness.Keywords
This publication has 28 references indexed in Scilit:
- Optimal cut-off for obesity and markers of metabolic syndrome for Ethiopian adultsNutrition Journal, 2018
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West EthiopiaBMC Infectious Diseases, 2016
- Book Review: Working to Overcome the Global Impact of Neglected Tropical DiseasesPerspectives in Public Health, 2012
- A ‘missing’ family of classical orthogonal polynomialsJournal of Physics A: Mathematical and Theoretical, 2011
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?Nature Reviews Microbiology, 2007
- Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Patients in Southern SudanClinical Infectious Diseases, 2004
- Visceral leishmaniasis and HIV in Tigray, EthiopiaTropical Medicine & International Health, 2003
- Prognostic Factors for Death from Visceral Leishmaniasis in Teresina, BrazilInfection, 2003
- Visceral leishmaniasis in Ethiopia. IV. Prevalence, incidence and relation of infection to disease in an endemic areaPathogens and Global Health, 1994